162 related articles for article (PubMed ID: 23871550)
1. Environmental tobacco smoke and arsenic methylation capacity are associated with urothelial carcinoma.
Wu CC; Chen MC; Huang YK; Huang CY; Lai LA; Chung CJ; Shiue HS; Pu YS; Lin YC; Han BC; Wang YH; Hsueh YM
J Formos Med Assoc; 2013 Sep; 112(9):554-60. PubMed ID: 23871550
[TBL] [Abstract][Full Text] [Related]
2. The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype.
Chung CJ; Huang CY; Pu YS; Shiue HS; Su CT; Hsueh YM
Toxicol Appl Pharmacol; 2013 Jan; 266(2):254-9. PubMed ID: 23159782
[TBL] [Abstract][Full Text] [Related]
3. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235
[TBL] [Abstract][Full Text] [Related]
4. Comparison of genome-wide DNA methylation in urothelial carcinomas of patients with and without arsenic exposure.
Yang TY; Hsu LI; Chiu AW; Pu YS; Wang SH; Liao YT; Wu MM; Wang YH; Chang CH; Lee TC; Chen CJ
Environ Res; 2014 Jan; 128():57-63. PubMed ID: 24268366
[TBL] [Abstract][Full Text] [Related]
5. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer.
Chen YC; Su HJ; Guo YL; Houseman EA; Christiani DC
Cancer Causes Control; 2005 Mar; 16(2):75-81. PubMed ID: 15868449
[TBL] [Abstract][Full Text] [Related]
6. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.
Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ
J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of TNF-
Wu CC; Huang YK; Huang CY; Shiue HS; Pu YS; Su CT; Lin YC; Hsueh YM
Biomed Res Int; 2018; 2018():3148137. PubMed ID: 29951534
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of human 8-oxoguanine DNA glycosylase 1 and 8-hydroxydeoxyguanosine increase susceptibility to arsenic methylation capacity-related urothelial carcinoma.
Huang CY; Pu YS; Shiue HS; Chen WJ; Lin YC; Hsueh YM
Arch Toxicol; 2016 Aug; 90(8):1917-27. PubMed ID: 26359225
[TBL] [Abstract][Full Text] [Related]
9. Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma.
Chung CJ; Pu YS; Su CT; Huang CY; Hsueh YM
Sci Total Environ; 2011 Jan; 409(3):465-70. PubMed ID: 21094982
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.
Wu CC; Huang YK; Chung CJ; Huang CY; Pu YS; Shiue HS; Lai LA; Lin YC; Su CT; Hsueh YM
Toxicol Appl Pharmacol; 2013 Oct; 272(1):30-6. PubMed ID: 23727622
[TBL] [Abstract][Full Text] [Related]
11. Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility.
Huang YK; Pu YS; Chung CJ; Shiue HS; Yang MH; Chen CJ; Hsueh YM
Food Chem Toxicol; 2008 Mar; 46(3):929-38. PubMed ID: 18054417
[TBL] [Abstract][Full Text] [Related]
12. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Jan; 226(1):14-21. PubMed ID: 17950770
[TBL] [Abstract][Full Text] [Related]
13. Measurement of urinary arsenic profiles and DNA hypomethylation in a case-control study of urothelial carcinoma.
Chung CJ; Lee HL; Chang CH; Chang H; Liu CS; Jung WT; Liu HJ; Liou SH; Chung MC; Hsueh YM
Arch Toxicol; 2019 Aug; 93(8):2155-2164. PubMed ID: 31363818
[TBL] [Abstract][Full Text] [Related]
14. Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma.
Wu CC; Su CT; Lee HL; Chung CJ; Huang CY; Pu YS; Lin P; Hsueh YM
J Urol; 2012 Nov; 188(5):1701-5. PubMed ID: 22998908
[TBL] [Abstract][Full Text] [Related]
15. Youth tobacco surveillance--United States, 2001-2002.
Marshall L; Schooley M; Ryan H; Cox P; Easton A; Healton C; Jackson K; Davis KC; Homsi G;
MMWR Surveill Summ; 2006 May; 55(3):1-56. PubMed ID: 16708059
[TBL] [Abstract][Full Text] [Related]
16. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
Wang YH; Yeh SD; Shen KH; Shen CH; Juang GD; Hsu LI; Chiou HY; Chen CJ
Toxicol Appl Pharmacol; 2009 Nov; 241(1):111-8. PubMed ID: 19686770
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma.
Chung CJ; Pu YS; Chen YT; Su CT; Wu CC; Shiue HS; Huang CY; Hsueh YM
Sci Total Environ; 2011 Feb; 409(6):1039-45. PubMed ID: 21227482
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Oct; 232(2):203-9. PubMed ID: 18640142
[TBL] [Abstract][Full Text] [Related]
19. Active cigarette smoking, secondhand smoke exposure at work and home, and self-rated health.
Nakata A; Takahashi M; Swanson NG; Ikeda T; Hojou M
Public Health; 2009 Oct; 123(10):650-6. PubMed ID: 19875139
[TBL] [Abstract][Full Text] [Related]
20. Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: a pooled analysis of two large studies.
Brennan P; Buffler PA; Reynolds P; Wu AH; Wichmann HE; Agudo A; Pershagen G; Jöckel KH; Benhamou S; Greenberg RS; Merletti F; Winck C; Fontham ET; Kreuzer M; Darby SC; Forastiere F; Simonato L; Boffetta P
Int J Cancer; 2004 Mar; 109(1):125-31. PubMed ID: 14735478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
